Alnylam Pharmaceuticals, Inc. (ALNY): PT Raised News

ALNY – Credit Suisse raises PT to $154 from $151. This new price target represents a 8.42% upside over the stock’s previous closing price of $142.04.

Update: As of Dec. 14, 2018, this bullish analyst call has returned -45.70%.

Key Facts Surrounding This News Item

  • ALNY had a POWR Rating of A (Strong Buy) coming into today.
  • ALNY was 12.79% above its 10-Day Moving Average coming into today.
  • ALNY was 15.25% above its 20-Day Moving Average coming into today.
  • ALNY was 12.59% above its 50-Day Moving Average coming into today.
  • ALNY was 12.52% above its 100-Day Moving Average coming into today.
  • ALNY was 33.38% above its 200-Day Moving Average coming into today.
  • ALNY had returned +11.80% year-to-date leading up to today’s news, versus a +4.37% return from the benchmark S&P 500 during the same period.

More Info About Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts. View our full ALNY ticker page with ratings, news, and more.

ALNY at a Glance

ALNY Current POWR Rating™
Overall POWR Rating™
ALNY Current Price $77.13 1.94%
More ALNY Ratings, Data, and News

ALNY Price Reaction

The day of this event (Mar. 13, 2018)
ALNY Closing Price$144.16 1.49%
ALNY Volume1,923,400
73.50% from avg
Leading up to this event
ALNY 1-mo return19.10%
After this event
ALNY 1-day return0.15%
ALNY 3-day return2.08%
ALNY 5-day return4.38%

ALNY Price Chart

The Top Stocks For 2019

More Alnylam Pharmaceuticals, Inc. (ALNY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ALNY News
Page generated in 1.0401 seconds.